{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:40:13Z","timestamp":1765294813938},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>The aim of this study is to evaluate the association between metabolic disorders and the risk of nasopharyngeal carcinoma, considering different histological subtypes. Between 1992 and 2008, we carried out a multicentre case\u2013control study in Italy. One-hundred and ninety-seven White patients with histologically confirmed nasopharyngeal carcinoma were enrolled as cases. The control group included 592 cancer-free patients, frequency matched by study centre, area of residence, sex, age and period of interview. Odds ratios (OR) and corresponding 95% confidence intervals (CI), for nasopharyngeal carcinoma according to obesity and self-reported history of other metabolic disorders, were calculated through logistic regression models adjusted for matching variables and tobacco smoking and drinking habits. Obesity (OR=1.44; 95% CI: 0.88\u20132.36), diabetes mellitus (OR=0.91; 95% CI: 0.42\u20131.98), hypertension (OR=0.79; 95% CI: 0.48\u20131.32), hypercholesterolaemia (OR=1.41; 95% CI: 0.84\u20132.35) and metabolic syndrome (i.e. at least three among the four previously cited metabolic disorders; OR=1.11; 95% CI: 0.86\u20131.43) were not significantly associated with the overall risk of nasopharyngeal carcinoma. However, the associations observed for diabetes mellitus, hypercholesterolaemia and metabolic syndrome were stronger among differentiated nasopharyngeal carcinomas than among undifferentiated ones. In particular, 21.7% of differentiated nasopharyngeal carcinoma cases and 7.8% of controls reported a history of metabolic syndrome (OR=3.37; 95% CI: 1.05\u201310.81). The results of the study indicated no overall association between metabolic disorders and nasopharyngeal carcinoma. Nonetheless, although the small sample size calls for caution in interpretation, metabolic disorders could increase the risk of differentiated nasopharyngeal carcinoma. This finding further supports a different aetiology of the two histological subtypes.<\/jats:p>","DOI":"10.1097\/cej.0000000000000286","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T16:05:08Z","timestamp":1471536308000},"page":"180-183","source":"Crossref","is-referenced-by-count":12,"title":["Metabolic disorders and the risk of nasopharyngeal carcinoma: a case\u2013control study in Italy"],"prefix":"10.1097","volume":"27","author":[{"given":"Antonella","family":"Zucchetto","sequence":"first","affiliation":[{"name":"Unit of Cancer Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Taborelli","sequence":"additional","affiliation":[{"name":"Unit of Cancer Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Bosetti","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, IRCCS \u2013 \u2018Mario Negri\u2019 Institute for Pharmacological Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Montella","sequence":"additional","affiliation":[{"name":"Unit of Epidemiology, IRC \u2018Fondazione Pascale National Cancer Institute\u2019, Naples"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan, Milan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Franchin","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, CRO Aviano National Cancer Institute, IRCCS, Aviano"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Libra","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences (Biometec), University of Catania, Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Serraino","sequence":"additional","affiliation":[{"name":"Unit of Cancer Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Polesel","sequence":"additional","affiliation":[{"name":"Unit of Cancer Epidemiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0895-4356(01)00362-6","article-title":"Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls","volume":"54","author":"Bosetti","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1634\/theoncologist.2009-0300","article-title":"Risk of cancer following hospitalization for type 2 diabetes","volume":"15","author":"Hemminki","year":"2010","journal-title":"Oncologist"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.oraloncology.2011.03.017","article-title":"Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population","volume":"47","author":"Polesel","year":"2011","journal-title":"Oral Oncol"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(10)60706-4","article-title":"Linking diabetes and cancer: a consensus on complexity","volume":"375","author":"Renehan","year":"2010","journal-title":"Lancet"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ije\/dyv001","article-title":"Metabolic risk score and cancer risk: pooled analysis of seven cohorts","volume":"44","author":"Stocks","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1158\/1055-9965.EPI-11-0590","article-title":"History of diabetes and risk of head and neck cancer: a pooled analysis from the International Head and Neck Cancer Epidemiology Consortium","volume":"21","author":"Stott-Miller","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.canep.2013.03.006","article-title":"Type II diabetes and metabolic syndrome in relation to head and neck squamous cell carcinoma risk: a SEER-Medicare database study","volume":"37","author":"Stott-Miller","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamaoto.2014.1258","article-title":"Risk of head and neck cancer in patients with diabetes mellitus: a retrospective cohort study in Taiwan","volume":"140","author":"Tseng","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R15-20230901","first-page":"587","article-title":"Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type","volume":"5","author":"Vaughan","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.oraloncology.2011.04.011","article-title":"Association between metabolic syndrome and oral pre-malignancy: a community- and population-based study (KCIS No. 28)","volume":"47","author":"Yen","year":"2011","journal-title":"Oral Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201803000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:04:08Z","timestamp":1693613048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201803000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000286","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}